{"id":24376,"date":"2021-04-29T17:18:40","date_gmt":"2021-04-29T14:18:40","guid":{"rendered":"https:\/\/saudishopper.com.sa\/en\/?p=24376"},"modified":"2026-03-27T22:17:05","modified_gmt":"2026-03-27T19:17:05","slug":"hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region","status":"publish","type":"post","link":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/","title":{"rendered":"Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>London, United Kingdom,\u00a029 April 2021-(<\/strong><a href=\"http:\/\/aetoswire.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">AETOSWire<\/a>): Hikma Pharmaceuticals PLC (Hikma) and\u00a0Melinta Therapeutics (Melinta) today announced they have entered into an exclusive licensing agreement for Vabomere<sup>\u00ae<\/sup>\u00a0(meropenem and vaborbactam)\u00a0and Orbactiv<sup>\u00ae\u00a0<\/sup>(oritavancin), two novel anti-infective injectable products, for the Middle East and North Africa (MENA) region.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the United States, Orbactiv<strong><sup>\u00ae<\/sup><\/strong>&nbsp;is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections due to designated susceptible Gram-positive pathogens and Vabomere<strong><sup>\u00ae<\/sup><\/strong>&nbsp;is indicated for the treatment of patients 18 years of age and older with complicated urinary tract infections, including pyelonephritis, caused by&nbsp;designated susceptible Gram-negative pathogens.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under the terms of the agreement, Hikma is responsible for the registration and commercialisation of these two products across its 18 MENA markets. This extends Hikma\u2019s existing partnership with Melinta for their&nbsp;intravenous and oral formulations of Baxdela<sup>\u00ae<\/sup>&nbsp;(delafloxacin), a novel antibiotic product. The addition of these two innovative products to Hikma\u2019s portfolio builds on its hospital anti-infective franchise and provides healthcare professionals with more treatment options.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are excited to be extending our partnership with Melinta and bring Vabomere<sup>\u00ae<\/sup>\u00a0and Orbactiv<sup>\u00ae<\/sup>\u00a0to our patients in MENA,\u201d said Mazen Darwazah, Hikma\u2019s Executive Vice Chairman and President of MENA. \u201cAs one of the leading suppliers in the region, it is our responsibility to equip doctors with the latest and most innovative developments to treat their patients. This agreement supports our strategy of establishing a global network of partners to strengthen our portfolio and improve availability of treatment options in the MENA region.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cHikma shares our commitment to ensure that all patients who need our life-saving therapies can get them,\u201d said Christine Ann Miller, President and Chief Executive Officer of Melinta. \u201cWe\u2019re thrilled to extend our partnership to reach patients in need in the MENA region with Vabomere\u00ae and Orbactiv<sup>\u00ae<\/sup>.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>London, United Kingdom,\u00a029 April 2021-(AETOSWire): Hikma Pharmaceuticals PLC (Hikma) and\u00a0Melinta Therapeutics (Melinta) today announced they have entered into an exclusive licensing agreement for Vabomere\u00ae\u00a0(meropenem and vaborbactam)\u00a0and Orbactiv\u00ae\u00a0(oritavancin), two novel anti-infective injectable products, for the Middle East and North Africa (MENA) region.\u00a0 In the United States, Orbactiv\u00ae&nbsp;is indicated for the treatment of adult patients with acute [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":15745,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_meta-robots-noindex":"","_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","_pr_autopilot_social_copy":"","_yoast_wpseo_opengraph_title":"","_yoast_wpseo_opengraph_description":"","_yoast_wpseo_opengraph_image":"","_yoast_wpseo_opengraph_image_id":0,"_yoast_wpseo_twitter_title":"","_yoast_wpseo_twitter_description":"","_yoast_wpseo_twitter_image":"","_yoast_wpseo_twitter_image_id":0,"_yoast_wpseo_primary_category":72,"_extra_hide_author_box":"","_extra_featured_post":"","_partner_post_id":0,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-24376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-tech","et-has-post-format-content","et_post_format-et-post-format-standard"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>exclusive licensing agreement - Hikma and Melinta | Saudi Shopper<\/title>\n<meta name=\"description\" content=\"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"exclusive licensing agreement - Hikma and Melinta | Saudi Shopper\" \/>\n<meta property=\"og:description\" content=\"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/\" \/>\n<meta property=\"og:site_name\" content=\"Saudishopper\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaudiShopper\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T14:18:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-27T19:17:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3000\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nour Elotaiby\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ssict\" \/>\n<meta name=\"twitter:site\" content=\"@ssict\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nour Elotaiby\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/\"},\"author\":{\"name\":\"Nour Elotaiby\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#\\\/schema\\\/person\\\/e270afe93563c3ba9c14eea256a983d7\"},\"headline\":\"Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region\",\"datePublished\":\"2021-04-29T14:18:40+00:00\",\"dateModified\":\"2026-03-27T19:17:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/\"},\"wordCount\":326,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Hikma_Pharmaceuticals-Logo.wine_.png\",\"articleSection\":[\"Health &amp; Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#respond\"]}],\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/\",\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/\",\"name\":\"exclusive licensing agreement - Hikma and Melinta | Saudi Shopper\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Hikma_Pharmaceuticals-Logo.wine_.png\",\"datePublished\":\"2021-04-29T14:18:40+00:00\",\"dateModified\":\"2026-03-27T19:17:05+00:00\",\"description\":\"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#primaryimage\",\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Hikma_Pharmaceuticals-Logo.wine_.png\",\"contentUrl\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Hikma_Pharmaceuticals-Logo.wine_.png\",\"width\":3000,\"height\":2000,\"caption\":\"Hikma_Pharmaceuticals-Logo.wine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/\",\"name\":\"Saudishopper\",\"description\":\"Saudi ICT Shopper News\",\"publisher\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#organization\",\"name\":\"Saudi ICT News\",\"alternateName\":\"Saudi ICT Shopper News\",\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/SSTrans.png\",\"contentUrl\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/SSTrans.png\",\"width\":423,\"height\":165,\"caption\":\"Saudi ICT News\"},\"image\":{\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SaudiShopper\",\"https:\\\/\\\/x.com\\\/ssict\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/#\\\/schema\\\/person\\\/e270afe93563c3ba9c14eea256a983d7\",\"name\":\"Nour Elotaiby\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g\",\"caption\":\"Nour Elotaiby\"},\"url\":\"https:\\\/\\\/saudishopper.com.sa\\\/en\\\/author\\\/nour\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"exclusive licensing agreement - Hikma and Melinta | Saudi Shopper","description":"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/","og_locale":"en_US","og_type":"article","og_title":"exclusive licensing agreement - Hikma and Melinta | Saudi Shopper","og_description":"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.","og_url":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/","og_site_name":"Saudishopper","article_publisher":"https:\/\/www.facebook.com\/SaudiShopper","article_published_time":"2021-04-29T14:18:40+00:00","article_modified_time":"2026-03-27T19:17:05+00:00","og_image":[{"width":3000,"height":2000,"url":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png","type":"image\/png"}],"author":"Nour Elotaiby","twitter_card":"summary_large_image","twitter_creator":"@ssict","twitter_site":"@ssict","twitter_misc":{"Written by":"Nour Elotaiby","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#article","isPartOf":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/"},"author":{"name":"Nour Elotaiby","@id":"https:\/\/saudishopper.com.sa\/en\/#\/schema\/person\/e270afe93563c3ba9c14eea256a983d7"},"headline":"Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region","datePublished":"2021-04-29T14:18:40+00:00","dateModified":"2026-03-27T19:17:05+00:00","mainEntityOfPage":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/"},"wordCount":326,"commentCount":0,"publisher":{"@id":"https:\/\/saudishopper.com.sa\/en\/#organization"},"image":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#primaryimage"},"thumbnailUrl":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png","articleSection":["Health &amp; Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#respond"]}],"copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/saudishopper.com.sa\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/","url":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/","name":"exclusive licensing agreement - Hikma and Melinta | Saudi Shopper","isPartOf":{"@id":"https:\/\/saudishopper.com.sa\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#primaryimage"},"image":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#primaryimage"},"thumbnailUrl":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png","datePublished":"2021-04-29T14:18:40+00:00","dateModified":"2026-03-27T19:17:05+00:00","description":"Exclusive licensing agreement for Vabomere and Orbactiv in the Middle East and North Africa. Hikma and Melinta announce new anti-infectives.","breadcrumb":{"@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#primaryimage","url":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png","contentUrl":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/11\/Hikma_Pharmaceuticals-Logo.wine_.png","width":3000,"height":2000,"caption":"Hikma_Pharmaceuticals-Logo.wine"},{"@type":"BreadcrumbList","@id":"https:\/\/saudishopper.com.sa\/en\/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/saudishopper.com.sa\/en\/"},{"@type":"ListItem","position":2,"name":"Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region"}]},{"@type":"WebSite","@id":"https:\/\/saudishopper.com.sa\/en\/#website","url":"https:\/\/saudishopper.com.sa\/en\/","name":"Saudishopper","description":"Saudi ICT Shopper News","publisher":{"@id":"https:\/\/saudishopper.com.sa\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/saudishopper.com.sa\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/saudishopper.com.sa\/en\/#organization","name":"Saudi ICT News","alternateName":"Saudi ICT Shopper News","url":"https:\/\/saudishopper.com.sa\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/saudishopper.com.sa\/en\/#\/schema\/logo\/image\/","url":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/08\/SSTrans.png","contentUrl":"https:\/\/saudishopper.com.sa\/en\/wp-content\/uploads\/2020\/08\/SSTrans.png","width":423,"height":165,"caption":"Saudi ICT News"},"image":{"@id":"https:\/\/saudishopper.com.sa\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaudiShopper","https:\/\/x.com\/ssict"]},{"@type":"Person","@id":"https:\/\/saudishopper.com.sa\/en\/#\/schema\/person\/e270afe93563c3ba9c14eea256a983d7","name":"Nour Elotaiby","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e27a3f377f4ef014b4334305e358f12befadbb055d461166d37c62c672332d9d?s=96&d=https%3A%2F%2Fsaudishopper.com.sa%2Fen%2Fwp-content%2Fuploads%2F2020%2F12%2Fcropped-ss-icon--150x150.png&r=g","caption":"Nour Elotaiby"},"url":"https:\/\/saudishopper.com.sa\/en\/author\/nour\/"}]}},"_links":{"self":[{"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/posts\/24376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/comments?post=24376"}],"version-history":[{"count":1,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/posts\/24376\/revisions"}],"predecessor-version":[{"id":67864,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/posts\/24376\/revisions\/67864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/media\/15745"}],"wp:attachment":[{"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/media?parent=24376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/categories?post=24376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saudishopper.com.sa\/en\/wp-json\/wp\/v2\/tags?post=24376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}